NCT00502892View on ClinicalTrials.gov

Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Solid Tumors
Interventions
DRUG

Topotecan

0.5 mg/m\^2 IV Daily x 3 Days

DRUG

Ifosfamide

1.8 grams/m\^2 IV Over 1 Hour x 5 Days

DRUG

Carboplatin

AUC = 3 mg/ml/min IV Over 1 Hour x 3 Days \[for patients \> 22 yrs of age, 3 mg/mL/min IV Over 1 Hour x 2 Days\]

Trial Locations (1)

77030

U.T.M.D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00502892 - Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors | Biotech Hunter | Biotech Hunter